Tag Archives: Patent Law

Myriad Weighs In At The Federal Circuit

Posted on October 29, 2010 by Warren Woessner

On October 22d, Myriad, represented by a Jones Day team, weighed in – literally – at the Federal Circuit with a 63 page brief supporting its appeal of Judge Sweet’s decision that claims directed to isolated DNA sequences are unpatentable … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Bilski, Federal Circuit, intellectual property, Myriad, Patent Law, Warren Woessner | Leave a comment

ACI 12th Advanced Forum on Biotech Patents

Posted on October 28, 2010 by Warren Woessner

This well-known meeting/master patent drafting class will be held in Boston, MA from November 30 to December 2. On December 1, Warren Woessner will be speaking on the topic, “Are Genes Patentable? Examining the Potential Ramifications of Myriad and Developing Practical … Continue reading →

Posted in Conferences and Classes | Tagged biotechnology, biotechnology law, biotechnology news, intellectual property, Patent Law, Warren Woessner | Leave a comment

US Patent Law – Discouraging an International Business Model?

Posted on October 28, 2010 by Warren Woessner

In the recent decision of Solvay S.A. v. Honeywell International, Inc. (2009-1161, Fed. Cir. 2010), the Federal Circuit held that despite both being first to possess an invention in the U.S. and practicing reasonable diligence prior to filing, Honeywell did … Continue reading →

Posted in Interferences | Tagged Federal Circuit, intellectual property, Nicholas Lanzatella, Patent Law, Warren Woessner | Leave a comment

Director Kappos “Chats” About PTO S.W.O.T.

Posted on October 21, 2010 by Warren Woessner

Wednesday noon at the AIPLA 2010 Annual Meeting, USPTO Director David Kappos engaged in a “fireside chat” (actually podium-side chat) with AIPLA Executive Director and former PTO Director Q. Todd Dickinson about the Strengths, Weaknesses, Opportunities and Threats that he has … Continue reading →